BRAF and MEK inhibitors rechallenge after an adverse drug reaction in patients with cancer: A pharmacovigilance cohort study

Authors: Ezine, Emilien ^{a, b}, Da Silva, Angélique ^{c, d}, Idoudi, Safa ^a, Lebbe, Céleste ^{a, b}, Chrétien, Basile ^e, Sassier, Marion ^c, Alexandre, Joachim ^f, Dolladille, Charles ^{f, *}

Source: In Therapies December 2024

Does COVID‐19 pandemic impact cancer outcomes in metastatic setting? A comparative cohort study among metastatic patients treated at day care hospital

Authors: Quilan, Florian, Lequesne, Justine, Cherifi, François, Bastien, Etienne, Morel, Adeline, Delcambre, Corinne, Da Silva, Angélique, Grellard, Jean‐Michel, Leconte, Alexandra, Faveyrial, Audrey, Clarisse, Bénédicte, Joly, Florence

Source: Cancer medicine. 12(17):17603-17612

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100194557199.0x000001&indx=1&recIds=ETOCvdc_100194557199.0x000001

Atrial Fibrillation Incidence Associated With Exposure to Anticancer Drugs Used as Monotherapy in Clinical Trials

Authors: Alexandre, Joachim, Boismoreau, Louis, Morice, Pierre-Marie, Sassier, Marion, Da-Silva, Angélique, Plane, Anne-Flore, Font, Jonaz, Milliez, Paul, Legallois, Damien, Dolladille, Charles

Source: In JACC: CardioOncology April 2023 5(2):216-226

Ibrutinib and acalabrutinib use and risk of incident atrial fibrillation: a propensity-matched analysis.

Authors: Alexandre, Joachim, Font, Jonaz, Lenormand, Thibault, Chantepie, Sylvain, Bardet, Hippolyte, Damaj, Gandhi, Dolladille, Charles, Legallois, Damien, Da-Silva, Angélique, Milliez, Paul, Bisson, Arnaud, Fauchier, Laurent

Source: Experimental Hematology & Oncology; 3/4/2025, Vol. 14 Issue 1, p1-4, 4p

Subject Terms: PROPORTIONAL hazards models, PROPENSITY score matching, ATRIAL fibrillation, PUBLIC health, BRUTON tyrosine kinase

Cardiovascular immunotoxicities associated with immune checkpoint inhibitors: a safety meta-analysis

Authors: Dolladille, Charles, Akroun, Julia, Morice, Pierre-Marie, Dompmartin, Anne, Ezine, Emilien, Sassier, Marion, Da-Silva, Angélique, Plane, Anne-Flore, Legallois, Damien, L'Orphelin, Jean-Mathieu, Alexandre, Joachim

Source: European heart journal. 42(48):4964-4977

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100137215975.0x000001&indx=1&recIds=ETOCvdc_100137215975.0x000001

Arterial hypertension associated with PARPi: A meta‐analysis of 41 placebo randomized controlled trials combined with a World Health Organization's pharmacovigilance study.

Authors: Blaize, Clémence, Surtouque, Ellina, Font, Jonaz, Dolladille, Charles, Postel‐Vinay, Sophie, Da Silva, Angélique, Alexandre, Joachim, Morice, Pierre‐Marie

Source: Fundamental & Clinical Pharmacology; Aug2024, Vol. 38 Issue 4, p610-629, 20p

Subject Terms: POLY ADP ribose, UBIQUINONES, HYPERTENSION, WORLD health, SURVIVAL analysis (Biometry), RANDOMIZED controlled trials, PLACEBOS

Company/Entity: WORLD Health Organization

Pharmacokinetics and pharmacodynamics of antibody-drug conjugates for the treatment of patients with breast cancer.

Authors: Cherifi, François, Da Silva, Angélique, Martins-Branco, Diogo, Awada, Ahmad, Nader-Marta, Guilherme

Source: Expert Opinion on Drug Metabolism & Toxicology; Jan/Feb2024, Vol. 20 Issue 1/2, p45-59, 15p

Nouvelle AMM : sacituzumab govitecan dans le cancer du sein triple négatif avancé ou métastatique en troisième ligne et plus

Authors: Kabirian, Rayan, Da Silva, Angélique

Source: Bulletin du cancer. 109(3):249-250

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN631505854&indx=1&recIds=ETOCRN631505854

Neurocognitive impairment in females with breast cancer treated with endocrine therapy and CDK4/6 inhibitors: a pharmacovigilance study using the World Health Organization's database.

Authors: Prevost, Rachel, Chretien, Basile, Minoc, Elise-Marie, Dolladille, Charles, Da-Silva, Angélique, Nehme, Ahmad, Joly, Florence, Lelong-Boulouard, Véronique, Bastien, Etienne

Source: Frontiers in Pharmacology; 2023, p1-8, 8p

Subject Terms: CYCLIN-dependent kinase inhibitors, HORMONE therapy, BREAST cancer, DATABASES, WORLD health

Company/Entity: WORLD Health Organization

Infections associated with clozapine: a pharmacovigilance study using VigiBase^®.

Authors: Chrétien, Basile, Brazo, Perrine, Da Silva, Angélique, Sassier, Marion, Dolladille, Charles, Lelong-Boulouard, Véronique, Alexandre, Joachim, Fedrizzi, Sophie

Source: Frontiers in Pharmacology; 2023, p1-10, 10p

Subject Terms: CLOZAPINE, DRUG monitoring, OLANZAPINE, CONCOMITANT drugs, VALPROIC acid, PROTON pump inhibitors, CLARITHROMYCIN, ARIPIPRAZOLE

Pretreatment neutrophil to lymphocyte ratio as prognostic factor in metastatic breast cancer treated with cyclin dependent kinase 4/6 inhibitors.

Authors: Rottier, Pauline, Emile, George, Johnson, Alison, Levy, Christelle, Allouache, Djelila, Hrab, Ioana, Segura, Carine, Morel, Adeline, Villemin, Maud, Dubot-Poitelon, Coraline, Boismoreau, Louis, Cherifi, François, Lequesne, Justine, Da Silva, Angélique

Source: Frontiers in Oncology; 1/19/2023, Vol. 13, p1-12, 12p

Subject Terms: NEUTROPHIL lymphocyte ratio, PROGNOSIS, KINASE inhibitors, PROGRESSION-free survival, CYCLINS, METASTATIC breast cancer, CYCLIN-dependent kinases, CYCLIN-dependent kinase inhibitor-2A

Abemaciclib‐induced reversible grade 4 nephrotoxicity

Authors: Da Silva, Angélique, Chretien, Basile, Alexandre, Joachim, Emile, George

Source: Breast journal. 26(11):2329-2330

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100110357670.0x000001&indx=1&recIds=ETOCvdc_100110357670.0x000001

How to improve adherence of guidelines for localized testicular cancer surveillance: A Delphi consensus study.

Authors: Da Silva, Angélique, Fléchon, Aude, Coquan, Elodie, Planchamp, François, Culine, Stéphane, Murez, Thibaut, Méjean, Arnaud, Pasquier, David, Chevreau, Christine, Fizazi, Karim, Thiery-Vuilemin, Antoine, Joly, Florence

Source: Frontiers in Oncology; 10/17/2022, Vol. 12, p1-11, 11p

Subject Terms: DELPHI method, ONCOLOGISTS, TESTICULAR cancer, UROLOGISTS, SEMINOMA, PHYSICIANS

Geographic Terms: UGANDA

Anticancer drugs associated with venous thromboembolic event: Analysis of the WHO pharmacovigilance database.

Authors: DA Silva, Angélique, Alexandre, Joachim, Laneelle, Damien, Sassier, Marion, Chrétien, Basile, Fedrizzi, Sophie, Joly, Florence, Emile, George, Bertoletti, Laurent, Mery, Benoite, Plane, Anne Flore, Legallois, Damien, Dolladille, Charles

Source: Journal of clinical oncology. 39(15 suppl):3094-3094

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173189975.0x000001&indx=1&recIds=ETOCvdc_100173189975.0x000001

Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer.

Authors: Dolladille, Charles, Ederhy, Stéphane, Sassier, Marion, Cautela, Jennifer, Thuny, Franck, Cohen, Ariel A., Fedrizzi, Sophie, Chrétien, Basile, Da-Silva, Angélique, Plane, Anne-Flore, Legallois, Damien, Milliez, Paul U., Lelong-Boulouard, Véronique, Alexandre, Joachim

Source: JAMA Oncology; Jun2020, Vol. 6 Issue 6, p865-871, 7p

Occurrence of Pancytopenia Among Patients With Cancer Treated With Poly(Adenosine Diphosphate–Ribose) Polymerase Inhibitors: A Pharmacoepidemiologic Study.

Authors: Morice, Pierre-Marie, Chrétien, Basile, Da Silva, Angélique, Dolladille, Charles, Alexandre, Joachim

Source: JAMA Oncology; Dec2021, Vol. 7 Issue 12, p1899-1900, 2p

HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer.

Authors: Cherifi, François^1,2 (AUTHOR), Da Silva, Angélique² (AUTHOR), Johnson, Alison² (AUTHOR), Blanc-Fournier, Cécile³ (AUTHOR), Abramovici, Olivia⁴ (AUTHOR), Broyelle, Antonin⁵ (AUTHOR), Levy, Christelle^1,2 (AUTHOR), Allouache, Djelila² (AUTHOR), Hrab, Ioana² (AUTHOR), Segura, Carine² (AUTHOR), Morel, Adeline² (AUTHOR), Villemin, Maud² (AUTHOR), Boscher, Clémence² (AUTHOR), Dubot-Poitelon, Coraline² (AUTHOR), Rottier, Pauline² (AUTHOR), Lequesne, Justine¹ (AUTHOR), Emile, George^1,2 (AUTHOR)

Source: BMC Cancer. 10/20/2022, Vol. 22 Issue 1, p1081-1081. 1p.

Subject Terms: *THERAPEUTIC use of antineoplastic agents, *HORMONES, *CELL receptors, *PROGNOSIS, *RETROSPECTIVE studies, *IMPACT of Event Scale, *COMBINED modality therapy, *BREAST tumors

Recurrence of Immune-Related Adverse Events After Immune Checkpoint Inhibitor Rechallenge—Reply.

Authors: Dolladille, Charles, Da-Silva, Angélique, Alexandre, Joachim

Source: JAMA Oncology; Nov2020, Vol. 6 Issue 11, p1814-1815, 2p

This result is not displayed to guests.
Login for full access.

Nouvelle AMM : sacituzumab govitecandans le cancer du sein triple négatif avancé ou métastatique en troisième ligne et plus

Authors: Kabirian, Rayan, Da Silva, Angélique

Source: Bulletin du Cancer; 20220101, Issue: Preprints